Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.

Auteurs

Jacobs L, Wauters N, Lablad Y, Morelle J, Taghavi M

  • Date de publication

    March 2024

  • Type

    Review

  • Review

    Antibodies (Basel)

  • Researcher's name

    WAUTERS Nader

  • Hôpital

    Hôpital Erasme

  • Service

    Médecine Interne

  • PMID

    38534211

  • DOI

    10.3390/antib13010021